Trial NCT01238146

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2011-02536
Secondary IDs: CDR0000687197 OSU-10040 U01CA076576

Last trial update was posted on 2013-06-06

MeSH Interventions

Bendamustine Hydrochloride Obatoclax Rituximab

MeSH Conditions

Lymphoma Lymphoma, B-Cell Lymphoma, B-Cell, Marginal Zone Lymphoma, Follicular Lymphoma, Mantle-Cell Lymphoma, Non-Hodgkin Recurrence

Other Conditions

Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Splenic Marginal Zone Lymphoma

Stopping Reasons

No patients accrued.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID